SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Maintains ResMed at Equal-Weight, Raises Target to $250

Wells Fargo maintained its Equal-Weight rating and raised its ResMed price target to $250 from $215.

RMD

Related stories